The efficacy of GR38032F, an Antagonist of 5-hydroxytryptamine-3 (5-HT3) in the prophylaxis of cisplatin (CDDP)-induced nausea and vomiting
- 31 August 1988
- journal article
- other
- Published by Elsevier in European Journal of Cancer and Clinical Oncology
- Vol. 24 (8), 1383-1384
- https://doi.org/10.1016/0277-5379(88)90235-0
Abstract
No abstract availableThis publication has 2 references indexed in Scilit:
- PREVENTION OF EMESIS IN PATIENTS RECEIVING CYTOTOXIC DRUGS BY GR38032F, A SELECTIVE 5-HT3 RECEPTOR ANTAGONISTThe Lancet, 1987
- Antiemetic Efficacy of High-Dose Metoclopramide: Randomized Trials with Placebo and Prochlorperazine in Patients with Chemotherapy-Induced Nausea and VomitingNew England Journal of Medicine, 1981